Aspen Pharmacare Holdings Limited
APNHF
$6.23
-$0.90-12.59%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -7.78% | -7.25% | 8.59% | 7.78% | 9.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.78% | -7.25% | 8.59% | 7.78% | 9.82% |
| Cost of Revenue | -3.42% | -2.86% | 1.68% | 0.93% | 16.03% |
| Gross Profit | -13.60% | -13.10% | 17.36% | 16.49% | 2.51% |
| SG&A Expenses | 11.02% | 11.67% | 12.32% | 11.48% | 7.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 78.02% | 77.90% | 52.57% | 51.43% | -478.08% |
| Total Operating Expenses | 2.13% | 2.72% | 7.04% | 6.25% | 10.64% |
| Operating Income | -41.39% | -41.05% | 16.36% | 15.50% | 7.14% |
| Income Before Tax | -219.70% | -220.39% | 14.49% | 13.64% | -13.44% |
| Income Tax Expenses | -76.89% | -76.75% | 40.26% | 39.22% | 2.33% |
| Earnings from Continuing Operations | -268.62% | -269.59% | 7.88% | 7.08% | -17.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -268.62% | -269.59% | 7.88% | 7.08% | -17.78% |
| EBIT | -41.39% | -41.05% | 16.36% | 15.50% | 7.14% |
| EBITDA | -37.71% | -37.35% | 16.09% | 15.22% | 7.85% |
| EPS Basic | -268.75% | -269.66% | 7.91% | 7.15% | -17.78% |
| Normalized Basic EPS | -51.13% | -50.86% | 14.55% | 13.75% | 7.65% |
| EPS Diluted | -268.75% | -269.66% | 7.91% | 7.15% | -17.78% |
| Normalized Diluted EPS | -51.13% | -50.86% | 14.55% | 13.75% | 7.65% |
| Average Basic Shares Outstanding | -0.05% | -0.05% | -0.05% | -0.05% | -0.02% |
| Average Diluted Shares Outstanding | -0.05% | -0.05% | -0.05% | -0.05% | -0.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | 0.02% | 0.02% | -- |